Skip to content
Research Article Open access CC BY 4.0

Occurrence Rate of Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Co - infection among Expectant Mothers Attending Antenatal Clinic in Rivers State University Teaching Hospital

Beatrice Wobiarueri Moore-Igwe, Beauty Eruchi Echonwere –Uwikor, Ransom Baribefii Jacob, Emmanuel-Nath Ogochukwu

International Blood Research & Reviews · pp. 1–10 · Published 3 Feb 2022

10.9734/ibrr/2022/v13i230170

Abstract

The global burden of co-infection with human immunodeficiency virus (HIV), hepatitis B and C virus (HBV and HCV) has a negative impact in Sub-Saharan Africa.When HIV, HBV and HCV co-exist, they become life threatening and with high fatality rate particularly in gestation in which transmission occurs vertically, causing fetal and neonatal hepatitis. The study aimed at examining the occurrence rate of Human Immunodeficiency Virus (HIV), Hepatitis B virus (HBV) and Hepatitis C Virus (HCV) co - infection among expectant mothers attending antenatal clinic in Rivers State University Teaching Hospital (RSUTH). The study population comprised of one hundred and fifty (150) pregnant women. Venous blood was used in the study and screened for hepatitis B surface antigen (HBsAg), anti-HCV, and anti-HIV antibodies using commercially available immunoassay test kits. The prevalence of HCV, HIV and HBsAg among the pregnant subjects in relation to age group 21-30 and 31-40 in the study revealed a seropositive percentage of 0.7% and 1.3%. The other groups, however, showed no positive result among the three viruses. Furthermore, 0.7% of the pregnant women in their first, second and third trimester were co-infected with HCV and HBsAg while 1.3% out of 36.7% and 0.7% out of 61.3% of pregnant women within the age groups 21-30 and 31-40 respectively were seropositive for HIV. In relation to gestational age, it was seen from the study that 0.7% of the pregnant women in their first, second and third trimester were seropositive for HCV and HBsAg respectively, while 2% of the HIV seropositive pregnant women were in their first trimester. The overall seroprevalence of HCV, HIV and HBsAg as revealed in the study showed that infection was found to be 2% respectively among the pregnant women. The reduced prevalence of hepatitis B (HBsAg), hepatitis C (HCV) and human immunodeficiency virus (HIV) infection observed in the study among pregnant women attending antenatal care in the Rivers State University Teaching Hospital may be attributed to the increase in the awareness amongst the general populace in Port Harcourt especially couples about the consequences of sexually transmitted diseases such as HIV, Hepatitis B as well as Hepatitis C. In other words, there is reduction in seroprevalence of HBsAg, HCV and HIV which is premised on the efficacy of sensitization particularly on HBV vaccination and preventive protocols for HIV.

Human immunodeficiency virus hepatitis B and C Virus co-infection pregnant women seroprevalence

References (22)

  1. 1 The American Journal of Tropical Medicine and Hygiene [DOI]
  2. 2 Epidemiology of viral hepatitis and HIV co-infection [DOI]
  3. 3 Hepatotoxicity Associated With Antiretroviral Therapy in Adults Infected With Human Immunodeficiency Virus and the Role of Hepatitis C or B Virus Infection [DOI]
  4. 4 Clinical implications of HIV and hepatitis B co-infection in Asia and Africa [DOI]
  5. 5 Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa [DOI]
  6. 6 Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study) [DOI]
  7. 7 Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti‐HBc: implications for transfusion transmission and donor screening [DOI]
  8. 8 Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B [DOI]
  9. 9 Sero-prevalence and risk factors of hepatitis B virus and human immunodeficiency virus infection among pregnant women in Bahir Dar city, Northwest Ethiopia: a cross sectional study [DOI]
  10. 10 Hepatitis B virus and hepatitis C virus in pregnant Sudanese women [DOI]
  11. 11 Viral hepatitis and HIV in Africa.
  12. 12 Prevalence, sociodemographic features and risk factors of Hepatitis B virus infection among pregnant women in Southwestern Nigeria [DOI]
  13. 13 The State of Hepatitis B and C in the Mediterranean and Balkan Countries: Report from a Summit Conference [DOI]
  14. 14 Hepatitis B virus infection amongst pregnant women in North-Eastern Nigeria- A call for action [DOI]
  15. 15 High Seroprevalence of HBV and HCV Infection in HIV-Infected Adults in Kigali, Rwanda [DOI]
  16. 16 Management of hepatitis C virus infection in HIV/HCV co-infected patients: Clinical review [DOI]
  17. 17 High Prevalence of Hepatitis B Virus Infection among Pregnant Women Attending Antenatal Care in Central Nigeria [DOI]
  18. 18 Hepatitis C virus prevalence and genetic diversity among pregnant women in Gabon, central Africa [DOI]
  19. 19 Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
  20. 20 Transmission of Hepatitis C Virus [DOI]
  21. 21 Prevalence of human immunodeficiency virus (HIV) infection among pregnant women in an antenatal clinic in Port-Harcourt, Nigeria [DOI]
  22. 22 Prevalence of Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infection Among Pregnant Women Attending Antenatal Clinics in Abuja, Nigeria [DOI]

Cited by 1

Prevalence of Occult Hepatitis B Infection among People Living with HIV/AIDS in Rivers State

Stephenson Lawson, Rhoda Nwalozie · South Asian Journal of Research in Microbiology · 2024

Article metrics

Real usage data collected on this platform.

44

Page views

0

PDF downloads

13

Outbound clicks

1

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.